New One-Shot knee cartilage repair shows promise in trial

NCT ID NCT04236739

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 3 trial tested a new one-step treatment called IMPACT for knee cartilage damage. It combines the patient's own cartilage cells with donor stem cells, applied during a single surgery. 60 people aged 18-45 with moderate to severe cartilage lesions were randomly assigned to either IMPACT or standard care (physical therapy and pain medication). The study aimed to see if IMPACT improves knee symptoms and quality of life more than standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a mixture of donor stem cells and the patient's own cartilage cells, applied with a glue-like gel during surgery
What this could lead to
If successful, this could offer a simpler, one-time surgical treatment for knee cartilage damage, potentially delaying or preventing osteoarthritis.
What could go wrong
This is a small Phase 3 trial with only 60 people. The treatment requires surgery, and long-term benefits or risks are not yet fully known. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTICULAR CARTILAGE LESION OF THE KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Medical Center Utrecht

    Utrecht, Utrecht, 3584 CX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.